Literature DB >> 17370058

Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men.

H B Holt1, S H Wild, A D Postle, J Zhang, G Koster, M Umpleby, F Shojaee-Moradie, K Dewbury, P J Wood, D I Phillips, C D Byrne.   

Abstract

AIMS/HYPOTHESIS: The regulation of cortisol metabolism in vivo is not well understood. We evaluated the relationship between cortisol metabolism and insulin sensitivity, adjusting for total and regional fat content and for non-alcoholic fatty liver disease.
MATERIALS AND METHODS: Twenty-nine middle-aged healthy men with a wide range of BMI were recruited. We measured fat content by dual-energy X-ray absorptiometry and magnetic resonance imaging (MRI), liver fat by ultrasound and MRI, the hypothalamic-pituitary-adrenal axis by adrenal response to ACTH(1-24), unconjugated urinary cortisol excretion, corticosteroid-binding globulin, and cortisol clearance by MS. We assessed insulin sensitivity by hyperinsulinaemic-euglycaemic clamp and by OGTT.
RESULTS: Cortisol clearance was strongly inversely correlated with insulin sensitivity (M value) (r = -0.61, p = 0.002). Cortisol clearance was increased in people with fatty liver compared with those without (mean+/-SD: 243 +/- 10 vs 158 +/- 36 ml/min; p = 0.014). Multiple regression modelling showed that the relationship between cortisol clearance and insulin sensitivity was independent of body fat. The relationship between fatty liver and insulin sensitivity was significantly influenced by body fat and cortisol clearance. CONCLUSIONS/
INTERPRETATION: Cortisol clearance is strongly associated with insulin sensitivity, independently of the amount of body fat. The relationship between fatty liver and insulin sensitivity is mediated in part by both fatness and cortisol clearance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17370058     DOI: 10.1007/s00125-007-0629-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

Review 1.  REVIEW: THE USE OF ISOTOPIC STEROIDS FOR THE MEASUREMENT OF PRODUCTION RATES IN VIVO.

Authors:  J F TAIT
Journal:  J Clin Endocrinol Metab       Date:  1963-12       Impact factor: 5.958

Review 2.  Review: The role of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Kristina M Utzschneider; Steven E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

3.  Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.

Authors:  N A Huizenga; J W Koper; P de Lange; H A Pols; R P Stolk; D E Grobbee; F H de Jong; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

4.  Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors:  S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

5.  Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients.

Authors:  G Targher; L Bertolini; G Zoppini; L Zenari; G Falezza
Journal:  Diabet Med       Date:  2005-09       Impact factor: 4.359

6.  Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.

Authors:  Jukka Westerbacka; Hannele Yki-Järvinen; Satu Vehkavaara; Anna-Maija Häkkinen; Ruth Andrew; Deborah J Wake; Jonathan R Seckl; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

7.  Portal and peripheral cortisol levels in obese humans.

Authors:  W Aldhahi; E Mun; A B Goldfine
Journal:  Diabetologia       Date:  2004-04-17       Impact factor: 10.122

8.  Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps.

Authors:  D T Finegood; R N Bergman; M Vranic
Journal:  Diabetes       Date:  1988-08       Impact factor: 9.461

9.  Effect of fat distribution on the pharmacokinetics of cortisol in obesity.

Authors:  S A Lottenberg; D Giannella-Neto; H Derendorf; M Rocha; A Bosco; S V Carvalho; A E Moretti; A C Lerário; B L Wajchenberg
Journal:  Int J Clin Pharmacol Ther       Date:  1998-09       Impact factor: 1.366

10.  The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.

Authors:  M Saruç; H Yüceyar; S Ayhan; N Türkel; I Tuzcuoglu; M Can
Journal:  Hepatogastroenterology       Date:  2003 May-Jun
View more
  16 in total

Review 1.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Comment on: Holt HB, Wild SH, Postle AD et al (2007) Cortisol clearance and associations with insulin sensitivity, body fat and fatty liver in middle-aged men. Diabetologia 50:1024-1032.

Authors:  M N Kerstens; R P F Dullaart
Journal:  Diabetologia       Date:  2007-06-22       Impact factor: 10.122

3.  Effects of dietary composition on energy expenditure during weight-loss maintenance.

Authors:  Cara B Ebbeling; Janis F Swain; Henry A Feldman; William W Wong; David L Hachey; Erica Garcia-Lago; David S Ludwig
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

4.  Do neighbourhoods matter? Neighbourhood disorder and long-term trends in serum cortisol levels.

Authors:  Akilah Dulin-Keita; Krista Casazza; Jose R Fernandez; Michael I Goran; Barbara Gower
Journal:  J Epidemiol Community Health       Date:  2010-08-24       Impact factor: 3.710

Review 5.  The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health.

Authors:  Marià Alemany
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

6.  Evening chronotype is associated with severe NAFLD in obesity.

Authors:  Claudia Vetrani; Luigi Barrea; Ludovica Verde; Gerardo Sarno; Annamaria Docimo; Giulia de Alteriis; Silvia Savastano; Annamaria Colao; Giovanna Muscogiuri
Journal:  Int J Obes (Lond)       Date:  2022-06-08       Impact factor: 5.551

7.  Adaptive genetic variation, stress and glucose regulation.

Authors:  Roxanne C Oriel; Christopher D Wiley; Michael J Dewey; Paul B Vrana
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

8.  Twenty-eight-day bed rest with hypercortisolemia induces peripheral insulin resistance and increases intramuscular triglycerides.

Authors:  Melanie G Cree; Douglas Paddon-Jones; Bradley R Newcomer; Ola Ronsen; Asle Aarsland; Robert R Wolfe; Arny Ferrando
Journal:  Metabolism       Date:  2009-11-17       Impact factor: 8.694

Review 9.  Splanchnic-aortic inflammatory axis in experimental portal hypertension.

Authors:  Maria-Angeles Aller; Natalia de las Heras; Maria-Paz Nava; Javier Regadera; Jaime Arias; Vicente Lahera
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

10.  Differential effects of fatness, fitness and physical activity energy expenditure on whole-body, liver and fat insulin sensitivity.

Authors:  H B Holt; S H Wild; N Wareham; U Ekelund; M Umpleby; F Shojaee-Moradie; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2007-05-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.